Clin2
NCT06305182Worth exploringRecruiting

Metreleptin for Anorexia Nervosa

Anorexia Nervosa

Treatments studied

Part of Mental health clinical trials.

This study tests a drug called metreleptin (a version of a hormone that helps regulate appetite and weight) in people hospitalized for anorexia nervosa. It may help with weight restoration and mood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
17 years to 65 years
Study type
Interventional

Who can take part

  • You are 17 to 65 years old.
  • You have a confirmed diagnosis of anorexia nervosa (by a doctor using standard criteria).
  • Your body mass index (BMI) is between 13 and 18, and you weigh at least 35 kg (about 77 lbs).
  • You are currently a patient in the Eating Disorders Unit at the University Hospital of Zurich.
  • You understand German well enough to talk with the study team.
  • You have mild to moderate depression symptoms (scores 8 or more on a depression scale).
  • You are not currently using drugs, do not have an alcohol problem, and do not have serious medical conditions like diabetes, autoimmune disorders, or cancer.
  • You are not pregnant or breastfeeding, and you use two forms of birth control if you could become pregnant.
  • You are not currently suicidal or engaging in serious self-harm.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07580209Recruiting
Brain hormone and metabolism study in anorexia nervosa

This research study examines how the brain regulates hormones and metabolism in people with long-standing anorexia nervosa. By comparing brain samples from people with the condition to healthy volunteers, researchers hope to understand the biological changes that occur and develop better treatments.

Zurich
NCT05885724Recruiting
Biomarker study in restrictive anorexia nervosa

This study measures “biomarkers” (blood or other body signs) to learn what may be unique in people with restrictive anorexia nervosa. The goal is to help researchers find targets that could guide future, more personalized care.

Basel
NCT05197309Recruiting
Metabolic diet to help prevent relapse in anorexia

This study tests whether a specific diet can help people with anorexia nervosa stay well and avoid relapse after weight restoration. It focuses on “metabolic” (energy and blood sugar-related) effects, checked with blood work and regular visits.

New York, New York
NCT06814002Recruiting
Trial on anxiety and metabolism in anorexia nervosa

This study looks at how anxiety and metabolism are connected in anorexia nervosa. If you are a teen girl newly diagnosed and not yet treated, you may help us learn more about these links.

Izmir
NCT06736769Enrolling by invitation· Phase 2
Ketamine and learning in eating disorders

This study tests whether a single dose of ketamine can help people with anorexia nervosa learn new ways of thinking about food and body image during recovery. You may be eligible if you are a teenager or young adult currently hospitalized for malnutrition.

San Francisco, California
NCT06000774Recruiting
Therapeutic Ketogenic Diet for Anorexia Nervosa

This study tests whether a therapeutic ketogenic diet (a very low-carb, high-fat eating plan) can help people with anorexia nervosa, including those who have recently recovered their weight and those who are still underweight. The diet may help improve brain function and reduce eating disorder symptoms.

San Diego, California

Hear when a new Anorexia Nervosa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.